What Is Ipamorelin? Research Overview of the Selective GH Secretagogue Peptide

Overview

Ipamorelin is a synthetic pentapeptide classified within the growth hormone secretagogue (GHS) family of research compounds. It was originally characterized in pharmacological literature during efforts to identify ghrelin receptor agonists with greater target selectivity than earlier secretagogues such as GHRP-6 and GHRP-2. In laboratory settings, Ipamorelin is studied as a tool compound for investigating growth hormone secretagogue receptor (GHSR-1a) signaling pathways, receptor binding kinetics, and downstream endocrine research models. This article is intended for educational and scientific reference purposes only.

Chemical Structure & Characteristics

Ipamorelin is a five-amino-acid peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) with a molecular formula of C38H49N9O5 and a molecular weight of approximately 711.85 g/mol. Its compact pentapeptide backbone, incorporating non-standard residues such as 2-aminoisobutyric acid (Aib) and D-configured amino acids, is thought to confer resistance to enzymatic degradation relative to linear peptide analogs, a property frequently discussed in structure-activity research on secretagogue peptides. As a lyophilized research material, it is typically supplied as a white to off-white powder for laboratory characterization work.

Mechanism of Action

Ipamorelin is studied for its activity as a selective agonist at the growth hormone secretagogue receptor (GHSR-1a), the same receptor targeted endogenously by ghrelin. Receptor-binding research indicates that Ipamorelin engages GHSR-1a in the hypothalamic-pituitary axis in animal models, triggering intracellular signaling cascades associated with growth hormone release from the anterior pituitary. A key area of ongoing research interest is Ipamorelin's comparative receptor selectivity: in vitro and animal-model studies suggest it produces minimal off-target activation of pathways associated with cortisol, prolactin, and adrenocorticotropic hormone (ACTH) release, distinguishing it from earlier-generation GH secretagogues in receptor pharmacology comparisons. This selectivity profile makes Ipamorelin a frequently referenced model compound in receptor specificity research.

Research Considerations

For laboratory applications, researchers commonly reference several handling considerations documented in peptide stability literature: lyophilized peptide materials are generally recommended for storage at -20 degrees C or below to preserve structural integrity prior to reconstitution for research assays, and reconstituted solutions are typically noted in the literature as having limited stability, warranting refrigerated storage and prompt use within study protocols. Purity verification via HPLC and mass spectrometry is standard practice for research-grade peptide materials to confirm identity and exclude degradation products before use in any experimental design. These notes are provided for general laboratory-handling context only and do not constitute usage, dosing, or administration instructions.

Preclinical Research Summary

Published pharmacological research has examined Ipamorelin primarily in rodent and other animal models to characterize GHSR-1a agonism, growth hormone pulsatility, and receptor selectivity relative to other secretagogues. These studies are conducted within controlled laboratory settings and contribute to the broader scientific understanding of ghrelin receptor pharmacology, GH axis regulation, and secretagogue peptide structure-activity relationships. Findings from this body of research are used by scientists to inform further in-vitro and animal-model investigation and are not indicative of outcomes in humans.

Research Use Only

Ipamorelin, as offered for reference in this Knowledge Center, is intended strictly for in-vitro laboratory research and is not approved, labeled, or intended for human or veterinary use, diagnosis, treatment, or prevention of any disease. This compound is not currently listed for sale on Apex Molecular Labs pending completion of certificate of analysis (COA) and third-party purity testing. All information presented here is educational and derived from publicly available scientific literature; it should not be construed as a recommendation for use outside of a qualified laboratory research setting, and any handling must comply with applicable local, state, and federal regulations governing research chemicals.